EZH2 is an epigenetic regulator of renal gluconeogenesis in chronic kidney disease through downregulation of PCK1

被引：0
|
作者：
Lin, Pinglan [1 ]
Wu, Ming [1 ]
Ye, Chaoyang [1 ]
机构：
[1] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Nephrol, Shanghai, Peoples R China
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2024年 / 39卷
关键词：
D O I：
10.1093/ndt/gfae069.471
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
1453
引用
收藏
页数：5
相关论文
共 50 条
  • [1] EZH2 is an epigenetic regulator of renal gluconeogenesis in chronic kidney disease through downregulation of PCK1
    Lin, Pinglan
    Wu, Ming
    Ye, Chaoyang
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I770 - I774
  • [2] EZH2 PROMOTES RENAL INTERSTITIAL FIBROSIS THROUGH DOWNREGULATION OF PHOSPHOENOLPYRUVATE CARBOXYKINASE 1 MEDIATED GLUCONEOGENESIS
    Bai, Yanfang
    Wu, Ming
    Ye, Chaoyang
    Chen, Dongping
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I445 - I445
  • [3] Anoctamin 3 inhibits gluconeogenesis and contributes to renal interstitial fibrosis through EZH2
    Wu, Ming
    Lin, Pinglan
    Ye, Chaoyang
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I764 - I767
  • [4] Anoctamin 3 inhibits gluconeogenesis and contributes to renal interstitial fibrosis through EZH2
    Wu, Ming
    Lin, Pinglan
    Ye, Chaoyang
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [5] Chronic kidney disease impairs glucose production through gluconeogenesis downregulation (NCCR project)
    Verissimo, Thomas
    Faivre, Anna
    Heckenmeyer, Carolyn
    Fernandez, Marylise
    Cippa, Pietro
    Legouis, David
    De Seigneux, Sophie
    SWISS MEDICAL WEEKLY, 2020, : 3S - 3S
  • [6] THE ROLE ANDMECHANISMOF EZH2 INVASCULAR CALCIFICATION ASSOCIATED WITH CHRONIC KIDNEY DISEASE
    Lin Pinglan
    Ye, Chaoyang
    Wu, Ming
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I41 - I46
  • [7] Reciprocal regulation of amino acid import and epigenetic state through Lat1 and EZH2
    Dann, Stephen G.
    Ryskin, Michael
    Barsotti, Anthony M.
    Golas, Jonathon
    Shi, Celine
    Miranda, Miriam
    Hosselet, Christine
    Lemon, Luanna
    Lucas, Judy
    Karnoub, Maha
    Wang, Fang
    Myers, Jeremy S.
    Garza, Scott J.
    Follettie, Maximillian T.
    Geles, Kenneth G.
    Klippel, Anke
    Rollins, Robert A.
    Fantin, Valeria R.
    EMBO JOURNAL, 2015, 34 (13): : 1773 - 1785
  • [8] EZH2 promotes metabolic reprogramming in glioblastomas through epigenetic repression of EAF2-HIF1α signaling
    Pang, Bo
    Zheng, Xiang-Rong
    Tian, Jing-xia
    Gao, Tai-hong
    Gu, Guang-yan
    Zhang, Rui
    Fu, Yi-Bing
    Pang, Qi
    Li, Xin-Gang
    Liu, Qian
    ONCOTARGET, 2016, 7 (29) : 45134 - 45143
  • [9] The Histone Methyltransferase Ezh2 Is a Crucial Epigenetic Regulator Of Allogeneic T Cell Responses and Graft-Versus-Host Disease In Mice
    He, Shan
    Xie, Fang
    Liu, Yongnian
    Tong, Qing
    Mochizuki, Kazuhiro
    Lapinski, Philip E.
    Reddy, Pavan
    Mochizuki, Izumi
    Chinnaiyan, Arul M.
    Mineishi, Shin
    King, Philip D.
    Zhang, Yi
    BLOOD, 2013, 122 (21)
  • [10] Prognostic and immunological significance of key gluconeogenesis regulators, PCK1 and PCK2, in human cancers especially kidney renal clear cell carcinoma: Insights from pan-cancer analysis, PCKs signature construction, and in vitro experiments
    Shang, Zebin
    Zhao, Haonan
    Yang, Tianhao
    Xue, Xuewen
    Zhao, Binggang
    Sun, Yujie
    JOURNAL OF RADIATION RESEARCH AND APPLIED SCIENCES, 2023, 16 (03)
12345